Valiant Laboratories Ltd

BSE Code : 543998
NSE Symbol : VALIANTLAB
ISIN : INE0JWS01017
Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

Trade Now

Get Quotes

90.19 -1.44(-1.57%)

Open Price (₹)

94.00

Prev. Close (₹)

91.63

Volume (No’s)

43,641

Market Cap (₹)

489.84

Low Price (₹)

88.41

High Price (₹)

94.00 Chart

Technical Chart

Corparate Information

Financials

Corporate Action

Book Closure

From Date	To Date	Announcement
28-Jul-2025	08-Aug-2025	Trading Members of the Exchange are hereby informed that dealings in the Rights Entitlements (REs) for Renunciation of VALIANT LABORATORIES LIMITED are permitted on the Exchange with effect from Monday, July 28, 2025. The details of Rights Entitlements (REs) are as under: Name of the Company VALIANT LABORATORIES LIMITED Type of Security Rights Entitlements (REs) Trading period for Renunciation of Rights Entitlements (REs) Monday, July 28, 2025 to Tuesday, August 05, 2025. Scrip Code 751016 Scrip ID VALIANT-RE ISIN No. INE0JWS20017 Market Lot 1 Group R Please note that the Rights Issue will open on July 28, 2025 to August 08, 2025. Trading Members are further requested to note that Rights Entitlements (REs) for Renunciation shall be settled on T+1 Rolling Settlement basis. The trades shall be settled on trade-for-trade basis. The Rights Entitlements shall be tradable in dematerialized form only. Trading members shall inform all its clients about the commencement of trading in REs mentioning the ISIN of the RE and that the same shall not be mistaken for ordinary shares of the concerned company. Trading members shall include a disclaimer prominently in the contract notes / bill containing purchase of REs informing the Clients that the purchase of REs only gives them the right to participate in the ongoing Rights Issue of the concerned company by making an application with requisite application money or renounce the REs before the issue closes. REs which are neither subscribed by making an application with requisite application money nor renounced, on or before the Issue Closing Date shall lapse and shall be extinguished after the Issue Closing Date.
19-Jul-2025	NA	1:4 Right Issue of Equity Shares Rights issue of Equity shares - Record date July 19, 2025 (As Per BSE Announcement dated on 15.07.2025)
19-Jul-2025	NA	1:4 Right Issue of Equity Shares Trading Members of the Exchange are hereby informed that VALIANT LABORATORIES LIMITED has fixed Record Date for the purpose of Rights Issue of Equity Shares of the Company. The transactions in the Equity Shares of the Company should be done on Ex-Rights Basis with effect from the under mentioned date:- DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE VALIANT LABORATORIES LIMITED (543998) RECORD DATE 19.07.2025 PURPOSE Issue of 01 (ONE) Equity Share of Rs 10/- each for cash at a Premium of Rs.65/- per share on Rights Basis for every 04 (FOUR) Equity Shares held.* Ex-Right basis from Date & Sett. No. 18/07/2025 DR-676/2025-2026 * As per Terms of Payment, The Full amount of the Issue Price being Rs.75/- per share will be payable on Application. Trading Members of the Exchange are requested to take note of it. (As Per BSE Notice Dated on 16.07.2025)
09-Jul-2025	NA	Valiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/07/2025 inter alia to consider and approve proposal for raising of funds by way of issue of securities through further public offer rights issue American Depository Receipts/ Global Depository Receipts/ Foreign Currency Convertible Bonds qualified institutions placement debt issue preferential issue or any other method as may be decided and considered appropriate subject to such regulatory/statutory approvals as may be required and matters related and incidental thereto. Considered and approved 1) Fund raising via Rights Issue and 2) Appointment of the Company Secretary and Compliance Officer The board on July 09, 2025, has considered and approved raising of via Rights Issue. (As Per BSE Announcement Dated on 09.07.2025)
09-Jul-2025	NA	Considered and approved 1) Fund raising via Rights Issue and 2) Appointment of the Company Secretary and Compliance Officer Appointed Mr. Akshay Gangurde (ICSI Membership Number: A70561) as the Company Secretary and Compliance Officer of the Company with effect from July 09, 2025.